Attachments
Summary
As of 5 February 2022, the total number of COVID-19 vaccines delivered to Syria through the COVAX Facility is 8 352 740, in addition to 2 713 640 doses received through bilateral agreements. These allocations are enough to cover 38% of the population. In the near future, over 3.7 million doses of COVID-19 vaccines are expected to be delivered through COVAX and will be sufficient to cover an additional 18.2% of the population.
In January 2021, the Ministry of Health received 151 200 doses of AstraZeneca/AZD1222 through COVAX donated by Japan, 1 million doses of Sinopharm donated by China, 368 640 doses of AstraZeneca by Oman, 302 400 doses of Johnson & Johnson donated by Spain, and 3 156 000 doses of Johnson & Johnson donated by Italy.
The last shipment received in northwest Syria was 832 800 doses of Johnson & Johnson donated by Italy on 23 December 2021.
The vaccines will be administered as part of the ongoing national vaccination campaign across the country.